Investments – Page 3

Novo Nordisk Invests $1.1 Billion to Expand GLP-1 Drug Manufacturing in Brazil

2 months ago talkbio0Tagged Brazil, Claros facility, Diabetes, Glucagon-Like Peptide 1, Investments, Montes, Nordisk, Obesity, Ozempic, pharmaceutical manufacturing, production, Wegovy

Novo Nordisk , GLP-1 production , Brazil investment , Wegovy and Ozempic , Diabetes treatment , Obesity treatment , Montes Claros facility , Pharmaceutical manufacturing

U.S. Congressional Report Calls for $15 Billion to Bolster Biotech Leadership Amid Rising Chinese Competition

2 months ago talkbio0Tagged Bioeconomy, Biomanufacturing Strategy, Biotech Competition, Biotechnology, Biotechnology Advantage, China, Investments, National Security Commission, Tech Rivalry, U.S.-China, United States

U.S. Biotechnology Advantage, China Biotech Competition, National Security Commission on Emerging Biotechnology, Biotechnology Investment, Biomanufacturing Strategy, U.S.-China Tech Rivalry, Bioeconomy

Stock market melts down over Trumps tariffs, and biotech’s pain keeps growing

2 months ago talkbio0Tagged Investments, Market

Market, Investments

DualityBio Pursues $200M IPO in Hong Kong Amid Volatile Market Conditions

2 months ago talkbio0Tagged Antibody-Drug, BioNTech, biotech sector, DualityBio, global trade tensions, Hong, Immunostimulating conjugate (antigen), Investments, IPO, Kong, Market, Stock exchange, upheaval

DualityBio, IPO, Hong Kong Stock Exchange, biotech investment, antibody-drug conjugates, BioNTech, market upheaval, global trade tensions, biotech sector growth.

Chiesi unveils 430M investment to revitalize Italian production site for inhaler, biologics manufacturing

3 months ago talkbio0Tagged Biological Factors, Inhaler, Investments, production

Investments, Inhaler, Biological Factors, production

AstraZeneca Makes Potential $10B+ China Commitment Despite Political Pressure

3 months ago talkbio0Tagged China, Evaluation procedure, Investments

Investments, China, Evaluation procedure

AstraZeneca details $2.5B investment in China’s political center, funding R&D center, biotech pacts

3 months ago talkbio0Tagged AstraZeneca, Beijing, China, China 's, Collaboration, Investments

Investments, AstraZeneca, Beijing, China, China ‘s, Collaboration

Johnson & Johnson Announces $55 Billion Investment in U.S. Manufacturing and Innovation

3 months ago talkbio0Tagged aligns, announcement, Benefit, capabilities, commitment, Corporation, domestic pharmaceutical industry, Increased, innovation, Investments, J&J 's, Manufacturing, Surgical construction, trends qualifier, United States

This major investment demonstrates J&J’s commitment to expanding its U.S. manufacturing and innovation capabilities, with potential benefits for job creation and the domestic pharmaceutical industry. The announcement aligns with broader trends of increased U.S. manufacturing investment by large corporations in recent years.